NL-OMON48295
Recruiting
Not Applicable
Identification of risk factors and biomarkers for liver diseases, hepatocellular carcinoma, cholangiocarcinoma and gallbladder carcinoma. The ESCALON stduy. - ESCALO
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Erasmus MC, Universitair Medisch Centrum Rotterdam
- Enrollment
- 1950
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •HPB related malignancies, • Age \>\= 18 years of age
- •Diagnosed with HCC, CCA or GBC
- •Written informed consent, HPB related diseases, • Age \>\= 18 years of age
- •Diagnosed with viral hepatitis, cirrhosis, PSC, NAFLD or gallstones
- •Written informed consent, Healthy controls, • Age \>\= 18 years of age
- •No signs of relevant disease
- •Written informed consent
Exclusion Criteria
- •For all groups, • Females who are pregnant or breast\-feeding.
- •History or other evidence of severe illness, other malignancy or any other
- •condition which would make the patient, in the opinion of the investigators,
- •unsuitable for the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Identification of the Risk factors Associated with Infertility and the Effect of Supportive Intervention on Quality of LifeHealth Condition 1: N00-N99- Diseases of the genitourinary systemCTRI/2022/05/042644Mrs Pon Princess Mano192
Recruiting
Not Applicable
Identification and analysis of biomarkers for the course of demyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosisDemyelinating and inflammatory diseases of the central nervous system, in particular multiple sclerosisDRKS00031139MPI-NAT1,000
Not yet recruiting
Not Applicable
Analysis for the prediction of systemic therapies in patients with locally advanced hepatocellular carcinomaNeoplasmsKCT0004206Seoul National University Hospital400
Completed
Not Applicable
Identification of predictive biomarkers for severe progression of COVID-19U07.1COVID-19, virus identifiedDRKS00021591Bundeswehrkrankenhaus Berlin, Klinik I (Innere Medizin)135
Active, not recruiting
Not Applicable
The study of possible risk factors associated with mild cognitive impairment in patients with the Metabolic SyndromeMetabolic syndromeMetabolic syndrome ,Mild Cognitive Impairment (MCI),Peripheral Markers,Neutrophil-Lymphocyte ratioTCTR20171004002Faculty of Medicine, Chiang Mai University300